News and Announcements
Red Cross Cell and Gene Therapy Starting Materials Now Available on Scientist.com
We’re excited to announce that Red Cross Cell and Gene Therapy Solutions can now be accessed through Scientist.com. This new channel makes it even easier for research teams to explore and request our specialized products. Explore our full range of allogeneic source materials, trusted by organizations advancing breakthrough cell and gene therapies, on Scientist.com and our product webpages.
Prepare Your LIS for New Platelet Product Codes
The American Red Cross is updating its platelet manufacturing process to increase efficiency and support a more sustainable blood supply. By early 2026, we will begin producing four platelet products from qualifying triple donations, an enhancement from the current standard of three.
To prepare for this upcoming change, hospitals will begin receiving the same platelet bags with an additional product code for the fourth unit. Please take action now by updating your Laboratory Information System (LIS) with the new product codes listed in the linked table.
A full list of product codes is available in the Hospital Partner Resource Guide (HPRG).
Advancing Infectious Disease Research and Diagnostics with American Red Cross Infectious Disease Blood Repository
The American Red Cross Infectious Disease Blood Repository (IDBR) is a curated collection of red cell and plasma samples confirmed positive for pathogens such as HIV, HCV, HBV, WNV, HTLV, Trypanosoma cruzi, Babesia spp., and syphilis. All specimens are screened using FDA-approved molecular and serologic assays, providing researchers and clinical laboratories with highly characterized materials to support diagnostic development, regulatory submissions, biomarker discovery, and technology validation.
As of July 1, IDBR samples are available for order through the Connect Order Management System, offering hospitals, academic institutions, and biotech companies access to verified positive specimens for assay validation, quality control, and research collaboration. Whether supporting translational studies or enhancing laboratory performance, the IDBR enables partners to work with confidence using well-documented, real-world specimens that meet rigorous quality standards. Learn more on our Infectious Disease Blood Repository webpage.
INTERCEPT® Fibrinogen Complex (IFC) A vital addition to your inventory for treating fibrinogen deficiency, offering consistent quality, extended shelf life, and improved logistics. Scheduled orders recommended, ad hoc ordering available.
Learn more >>
Order Now >>
Events
Gene Therapy Trial for Sickle Cell Disease
Speaker: Mark Walters, MD, University of California, San Francisco
Date: August 21
Sickle Cell Trait: Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT) Study and Our Testing
Speakers: Rakhi Naik, MD, MHA Johns Hopkins Medicine. Jenni Gasbarro American Red Cross
Date: September 4
Integrating RHD Genotyping for More Accurate Rh(D) Antigen Phenotyping and Blood Management
Speaker: Mohammad Barouqa, MD, University of South Alabama
Date: September 18
CAR-TCR Summit
Date: September 24 - September 25, 2025
Visit American Red Cross Cell and Gene Therapy Solutions at booth 35 on September 24 - September 25, 2025, in Boston, MA, at the CAR-TCR Summit.
Media Messaging Toolkit
The American Red Cross welcomes participation of our hospital partners in the recruitment of blood donors, especially in times of critical shortages. For your convenience, we have made available prepared messaging and graphics that can be used to promote the need for blood donations.
Blood Supply Messaging Resource Guide
Inform and engage your staff and community about the need for refueling the blood supply through blood and platelet donations.
Blood Saves Lives: Helping People with Sickle Cell Disease
Inform and engage your staff and community about the need for diverse donors to help patients battling sickle cell disease.
PLUS Online
An Educational Resource for Transfusion Medicine
Cold-Stored Platelets and Room Temperature Platelets
With the introduction of cold-stored platelets (CSP) into practice, transfusion services have encountered challenges in interpreting FDA guidance. The FDA indicates that CSP may be used to treat active bleeding when conventional platelets—room temperature platelets (RTP)—are unavailable or impractical to use.1 In addition, the FDA requires transfusion services to develop standard operating procedures (SOPs) that […]
Continue ReadingHow important is leukoreduction of low titer group O whole blood?
The use of low titer group O whole blood (LTOWB) has increased in recent years, predominantly in the setting of adult trauma resuscitation. While randomized control trials have not yet shown LTOWB to be superior to standard component therapy, several clinical trials designed to test this hypothesis are ongoing. Most LTOWB units undergo prestorage leukoreduction […]
Continue Reading